CAM
ALXN

Cozad Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Cozad Asset Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-880
Closed -$162K – 360
2021
Q2 		$162K Sell
880
-8,115
-90% -$1.39M 0.03% 338
2021
Q1 		$1.38M Sell
8,995
-705
-7% -$109K 0.22% 118
2020
Q4 		$1.52M Sell
9,700
-1,765
-15% -$227K 0.27% 105
2020
Q3 		$1.31M Sell
11,465
-14,260
-55% -$1.54M 0.25% 111
2020
Q2 		$2.89M Buy
25,725
+1,400
+6% +$149K 0.59% 48
2020
Q1 		$2.18M Buy
24,325
+2,780
+13% +$273K 0.76% 37
2019
Q4 		$2.33M Buy
21,545
+11,840
+122% +$1.27M 0.62% 49
2019
Q3 		$951K Buy
+9,705
New +$1.09M 0.27% 107

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Cozad Asset Management's ALXN Position: Q3 2021 in Review

Cozad Asset Management sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 880 shares — an estimated $162K sold.

Cozad Asset Management first reported a position in ALXN in Q3 2019 and held it in 8 quarters. The position peaked at $2.89M in Q2 2020. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Cozad Asset Management reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Cozad Asset Management sold 880 Alexion Pharmaceuticals shares in Q3 2021, an estimated $162K.
  • Cozad Asset Management first reported a position in Alexion Pharmaceuticals in Q3 2019 and held it in 8 quarters.
  • Cozad Asset Management's Alexion Pharmaceuticals position peaked at $2.89M in Q2 2020.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Cozad Asset Management's 13F filing for Q3 2021, filed 5 Nov 2021.